Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

SARDA PROTEINS LTD. - 519242 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Share Transfer Agent of the Company i.e. M/s. Link Intime India Private Limited has received information about loss of share certificate Shareholder. The duplicate share certificate/Letter of Confirmation will be issued only after the receipt of all necessary documents from the Shareholder.
06-03-2024
Bigul

SARDA PROTEINS LTD. - 519242 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the extract of Un-audited Financial Results for the quarter and nine months ended on 31st December, 2023 published by the Company in The Indian Express (English) and Business Remedies (Hindi) Newspaper on 15th February, 2024.
15-02-2024
Bigul

SARDA PROTEINS LTD. - 519242 - Un-Audited Financial Results For The Quarter And Nine Months Ended On 31St December, 2023

 Approved the Un-audited Financial Results of the Company along with Limited Review Report for the quarter and nine months ended on 31st December, 2023.
13-02-2024
Bigul

SARDA PROTEINS LTD. - 519242 - Board Meeting Outcome for Outcome Of The Board Meeting For Approval Of Un-Audited Financial Results Of The Company For The Quarter And Nine Months Ended On 31St December, 2023

 Approved the Un-audited Financial Results of the company for the quarter and nine months ended on 31st December, 2023 and took on record the Limited Review Report thereon. Further, the extract of the Un-audited Financial Results would also be published in the newspapers in compliance with Regulation 47 of Listing Regulations.
13-02-2024
Bigul

SARDA PROTEINS LTD. - 519242 - Board Meeting Intimation for Meeting To Be Held On Tuesday, 13Th February, 2024 At 01:00 P.M. At The Corporate Office Of The Company Situated At Inside Data Ingenious Global Limited, Station Road, Durgapura, Jaipur-302018 (Rajasthan)

 SARDA PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 ,inter alia, to consider and approve the Un-audited Financial Results of the company for the quarter and nine months ended on 31st December, 2023 and to take on record the Limited Review Report on the Un-audited Financial Results for the quarter and nine months ended on 31st December, 2023.
05-02-2024
Bigul

SARDA PROTEINS LTD. - 519242 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 We hereby enclose herewith the Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended on 31st December, 2023 received from M/s Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company.
09-01-2024
Bigul

SARDA PROTEINS LTD. - 519242 - Closure of Trading Window

 This is to inform you that pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (as amended) read with the Company''s Code of Conduct to regulate, monitor and report trading, the Trading Window for trading in the securities of the Company shall remain closed for Designated Persons of the Company and their relatives from 01stJanuary, 2024 till 48 hours after the announcement of the Financial Results of the Company for the quarter and nine months ended on 31stDecember, 2023. The date of meeting of the Board of Directors to approve the Financial Results of the Company for the quarter and nine months ended on 31stDecember, 2023 will be informed in due course.
29-12-2023
Bigul

SARDA PROTEINS LTD. - 519242 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of Security and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has received the enclosed register from our RTA -Link Intime India Private Limited, regarding the duplicate share certificates of the Company that have been issued. Pursuant to the SEBI Circular No. SEBI/HO/MJRSD/MIRSD _ RTAMB/P/2022/8 dated January 25, 2022, a letter of confirmation will be issued to the securities holder / claimant upon completion of necessary procedures regarding duplicate share certificates.
27-12-2023
Bigul

SARDA PROTEINS LTD. - 519242 - Appointment Of Mrs. Shipra Gandhi As The Chief Financial Officer (CFO) Of The Company.

 Pursuant to Regulation 30(2) read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby inform that based on the recommendation of Nomination and Remuneration Committee, the Board of Directors of the Company, at its meeting held on Thursday, 30th November, 2023 has appointed Mrs. Shipra Gandhi as the Chief Financial Officer (CFO) of the Company with effect from 01st December, 2023.Further, the details of the aforesaid Chief Financial Officer (CFO) required under Regulation 30 read with Part A of Schedule III of the Listing Regulations read with SEBI Circular CIR/CFD/CMD/4/2015 dated September 09, 2015 has been attached herewith as Annexure-A.
01-12-2023
Bigul

SARDA PROTEINS LTD. - 519242 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

 In terms of Regulation 30(2) read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company has received Resignation letter dated 08th November, 2023 from Mr. Somya Data, Chief Financial Officer (CFO) of the Company informing about his resignation from the post of Chief Financial Officer (CFO) due to some personal and unavoidable reason with effect from closure of business hours of 30th November, 2023. Further, the details of the aforesaid Chief Financial Officer (CFO) required under Regulation 30 read with Part A of Schedule III of the Listing Regulations read with SEBI Circular CIR/CFD/CMD/4/2015 dated September 09, 2015 has been attached herewith as Annexure-A.
09-11-2023
Next Page
Close

Let's Open Free Demat Account